Categories Cancer

-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial [unable to retrieve full-text content] The combination of dabrafenib and trametinib has shown activity in several BRAFV600E-mutated cancers. We aimed to assess the activity and safety of …Published at Mon, 17 Aug 2020 22:30:00 +0000

Read More
Categories Cancer

First Patient Dosed in Phase I/II Trial of Renal Cancer Imaging Product in Japan

First Patient Dosed in Phase I/II Trial of Renal Cancer Imaging Product in Japan TOKYO, Aug. 18, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Japan K.K., a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that the first patient has been dosed in a Phase I/II study of Telix’s […]

Read More
Categories Multiple Myeloma

Dr. Wong on the Potential Role of Venetoclax in Relapsed/Refractory AL Amyloidosis

Dr. Wong on the Potential Role of Venetoclax in Relapsed/Refractory AL Amyloidosis Sandy Wong, MD, discusses the potential role of venetoclax in relapsed/refractory light chain amyloidosis. Sandy Wong, MD, assistant professor, University of California, San Francisco (UCSF) School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the potential role of venetoclax (Venclexta) in […]

Read More
Categories Multiple Myeloma

Clinical Trials Are Pivotal in the Evolution of CAR-T Cell Therapy in Multiple Myeloma

Clinical Trials Are Pivotal in the Evolution of CAR-T Cell Therapy in Multiple Myeloma While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field […]

Read More
Categories Multiple Myeloma

Blood Cancer Drugs Market Size, Share, Growth, Trends, and Forecast, 2019 to 2023

Blood Cancer Drugs Market Size, Share, Growth, Trends, and Forecast, 2019 to 2023 Global “Blood Cancer Drugs market”- Report defines the vital growth factors, opportunities and market segment of top players during the forecast period from 2019 to 2025. The report Blood Cancer Drugs offers a complete market outlook and development rate during the past, […]

Read More